Latest News about Stories That Matter
Recent news which mentions Stories That Matter
From Benzinga
Nvidia Slides During Thursday Pre-Market Despite Beating Q3 Estimates: 'Even Outstanding Isn't Enough For Some Investors'
Today 6:47 EST
From Benzinga
Asia And Europe Markets Mixed; Dollar Hovers Near 52-Week High - Global Markets Today While US Slept
Today 6:40 EST
From Benzinga
From Benzinga
Elon Musk Says Amazon Founder Jeff Bezos Urged Tesla, SpaceX Investors To Dump Stakes, Predicting Trump's Loss
Today 3:26 EST
From Benzinga
SafeRent Settles $2.3M Discrimination Lawsuit Over Alleged AI Screening Bias Against Low-Income Renters
Today 3:20 EST
From Benzinga
Google's 'Unlawful Behavior' Stifles Market Entry For Rivals: DOJ Says Alphabet Must Sell Chrome To End Search Monopoly
Today 2:41 EST
From Benzinga
Why SpaceX Opted For Standard Starship Landing Over Elon Musk's Innovative 'Chopsticks' Technique
Today 1:55 EST
From Benzinga
Nvidia's Blackwell Set To Outpace Hopper? Here's What CEO Jensen Huang Predicts For 2025
Today 0:19 EST
From Benzinga
Elon Musk's Neuralink Gets Green Light To Launch Brain Chip Trial In Canada: 'Recruitment Is Now Open'
Today 0:15 EST
From Benzinga
Nvidia Stock Holding Up Better Than Gary Black's Expectations Amid Blackwell Chip Delays And Q4 Whisper Number Miss: Here's Why
November 20, 2024
From Benzinga
'Culture Is Not Something You Can Buy': Why Genuine Engagement Matters In Cannabis
November 20, 2024
Tickers
CCC
From Benzinga
'Struggle, Resiliency And A Positive Future': The Road Ahead for California's Cannabis Market
November 20, 2024
From Benzinga
Bitcoin Holding On To $94,000, Ethereum, Dogecoin Trade Lower: 'Place Your Bets, Up Or Down Brothers,' Says Trader
November 20, 2024
From Benzinga
DraftKings Analyst Sees Sports Betting Sector Growth, Positive Outcome From Paul Vs. Tyson Fight
November 20, 2024
From Benzinga
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
November 20, 2024
From Benzinga
Bitcoin To '$100,000 Is 'Programmed:' Dogecoin, Bonk To Benefit, Veteran Trader Says
November 20, 2024
From Benzinga
Roaring Kitty Ditched Chewy, Analyst Says You Should Adopt The Stock With 'Path To Pawsitive Growth'
November 20, 2024
Tickers
CHWY
From Benzinga
Eli Lilly, Verge Genomics Opt To Develop ALS Drug Candidate
November 20, 2024
From Benzinga
Walmart Posts Q3 Sales Beat, Raises Guidance: Analysts Expect Strong Earnings Growth Ahead
November 20, 2024
Tickers
WMT
From Benzinga
Fed's Bowman Warns On Inflation, Says Neutral Interest Rates May Be Closer 'Than We Currently Think'
November 20, 2024
From Benzinga
Muddy Waters' Carson Block Bets Against E.L.F. Beauty: Short Seller Says Retailer's Financials Show 'Major Red Flag'
November 20, 2024
From Benzinga
Big Pharma's Pharmacy-Benefit Managers Accuse FTC of Overreach In Effort to Reshape Drug Rebate System
November 20, 2024
From Benzinga
Inspire Medical's Strong 2025 Outlook And Upcoming Inspire V Launch Earns Analyst Upgrade
November 20, 2024
From Benzinga
Target Margins And Inventory Issues Raise Analyst Caution After Weak Q3 Performance
November 20, 2024
From Benzinga
CrowdStrike, Nasdaq, D.R. Horton And More On CNBC's 'Final Trades'
November 20, 2024
From Benzinga
Biogen Gains Momentum With Positive Lupus Drug Results, Analyst Sees Modest Valuation Upside
November 20, 2024
From Benzinga
Microsoft 'One Of The Most Compelling Investment Opportunities,' Says Goldman Sachs
November 20, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
